July 29, 2019 05:22 PM IST 
May 08, 2019 11:52 AM IST Motilal Oswal is bullish on Sanofi India has recommended buy rating on the stock with a target price of Rs 6930 in its research report dated May 07, 2019.
May 07, 2019 03:35 PM IST The company had posted a net profit of Rs 82.5 crore for the corresponding period of the previous fiscal, Sanofi India said in a filing to the BSE.
May 07, 2019 02:56 PM IST November 01, 2018 11:04 AM IST 
October 31, 2018 06:07 PM IST The company had posted a net profit of Rs 116.3 crore for the corresponding period of the previous fiscal, Sanofi India said in a filing to BSE.
October 31, 2018 04:43 PM IST August 06, 2018 03:28 PM IST The drug offers patients diagnosed with multiple sclerosis the efficacy and convenience of once-a-day oral treatment.
June 06, 2018 11:56 AM IST Traders can buy the stock around in dips around Rs 5,040-5,050 with a stop loss below Rs 4,880 (closing) for the target of Rs 5,335.
May 08, 2018 03:55 PM IST The company had posted a net profit of Rs 60.1 crore in January-March period of 2016-17, Sanofi India said in a filing to BSE.
April 16, 2018 05:05 PM IST Dolat Capital is bullish on Sanofi India has recommended buy rating on the stock with a target price of Rs 6000 in its research report dated April 13, 2018.
February 23, 2018 12:59 PM IST Centrum Research has recommended hold rating on Sanofi India with a target price of Rs 5160 in its research report dated February 23, 2018.
February 22, 2018 04:45 PM IST The company had posted a profit of Rs 52.6 crore for the corresponding period of the previous fiscal.
November 13, 2017 04:14 PM IST Motilal Oswal is bullish on Sanofi India has recommended Buy rating on the stock with a target price of Rs 5000 in its research report dated October 31, 2017.
November 02, 2017 03:04 PM IST Centrum is bullish on Sanofi India has recommended buy rating on the stock with a target price of Rs 4900 in its research report dated November 01, 2017.
September 11, 2017 04:19 PM IST Sanofi India's Consumer Healthcare Business Unit has a strong presence in four segments, namely pain-care, digestive health, allergy solutions, and vitamins, minerals and supplements.
May 08, 2017 06:01 PM IST Motilal Oswal is bullish on Sanofi India has recommended buy rating on the stock with a target price of Rs 4850 in its research report dated May 05, 2017.
May 05, 2017 08:14 PM IST Drug firm Sanofi India today reported a 27.36 percent dip in standalone net profit to Rs 60 crore for the first quarter ended March 31, 2017 on account of price reduction of drugs in the country and lower exports.
March 01, 2017 01:22 PM IST Motilal Oswal is bullish on Sanofi India has recommended buy rating on the stock with a target price of Rs 5000 in its research report dated February 28, 2017.
March 01, 2017 10:54 AM IST Centrum is bullish on Sanofi India has recommended buy rating on the stock with a target price of Rs 5330 in its research report dated February 28, 2017.
February 28, 2017 09:08 AM IST The company had reported a net profit of Rs 120.2 crore in the same period a year ago, Sanofi India said in a BSE filing.
February 28, 2017 09:00 AM IST L&T | Idea Cellular | ONGC | HPCL | Coal India | Sambhaav Media | Quess Corp | Merck | Assam Company | NHPC | Kohinoor Foods | LT Foods | KRBL | Adani Enterprises | Varun Beverages and BEML are stocks, which are in the news today.
November 30, 2016 11:24 AM IST Hugh Young, MD, Aberdeen Asset Management Asia is of the view that demonetisation is a big reform in a country like India where things usually move slowly.
November 18, 2016 06:07 PM IST Arihant Capital recommended hold rating on Sanofi India with a target price of Rs 4697 in its research report dated November 08, 2016.
November 17, 2016 04:02 PM IST The pact with NIPER "will promote academic excellence and research in the areas of pharmaceuticals and consumer healthcare products, to cater to the current and future needs of the pharmaceutical industry," Sanofi India said in a filing to BSE.
